Back
Novo Nordisk A/S Vs. Genmab A/S Industry Stock Comparison
Buy
78
NONOF
Novo Nordisk A/S
Last Price:
128.75
Seasonality Move:
4.69%
Sell
44
GMAB
Genmab A/S
Last Price:
28.84
Seasonality Move:
11.72%
Buy
78
Novo Nordisk A/S (NONOF)
is a Buy
Is Novo Nordisk A/S a Buy, Sell or Hold?
- The current Novo Nordisk A/S [NONOF] share price is $128.75. The Score for NONOF is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- NONOF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Genmab A/S (GMAB)
is a Sell
Is Genmab A/S a Buy, Sell or Hold?
- The current Genmab A/S [GMAB] share price is $28.84. The Score for GMAB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- GMAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $128.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NONOF is experiencing slight selling pressure.
GMAB Stock Price Chart
What is Genmab A/S's stock price today?
-
The Genmab A/S share price today is $28.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing slight buying pressure.
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.27 | Buy |
Relative Strength Index (14 RSI): | 56.53 | Buy |
Chaikin Money Flow: | -295 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (123.08 - 127.14) | Buy |
Bollinger Bands (100): | (109.22 - 129.32) | Buy |
GMAB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 49.34 | Sell |
Chaikin Money Flow: | 52482 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.19 - 29.57) | Sell |
Bollinger Bands (100): | (28.05 - 30.85) | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.45 | Buy |
20-day SMA: | 125.23 | Buy |
50-day SMA: | 127.18 | Buy |
200-day SMA: | 107.1 | Buy |
8-day EMA: | 126.34 | Buy |
20-day EMA: | 125.79 | Buy |
50-day EMA: | 124.5 | Buy |
200-day EMA: | 108.94 | Buy |
GMAB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.86 | Sell |
20-day SMA: | 28.66 | Buy |
50-day SMA: | 29.41 | Sell |
200-day SMA: | 31.86 | Sell |
8-day EMA: | 28.81 | Buy |
20-day EMA: | 28.85 | Sell |
50-day EMA: | 29.14 | Sell |
200-day EMA: | 31.59 | Sell |
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Genmab A/S Earnings Growth & GMAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.01 per share, an increase this year of $0.00 per share, and an increase next year of $0.45 per share.
Novo Nordisk A/S Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Genmab A/S Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |